GRCL — GRACELL BIOTECHNOLOGIES INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
GRCL (GRACELL BIOTECHNOLOGIES INC) is tracked on HoldingsHub across five years of quarterly 13F filings. 76 funds have reported positions historically, with the sum of their latest reported stakes valued at $5.18B. No fund in our coverage reported a position in the latest filing period, which typically means the stock has fallen out of the tracked funds' portfolios rather than that it cannot be bought.
Major shareholders of GRACELL BIOTECHNOLOGIES INC (GRCL) include MMCAP International Inc. SPC, Temasek Holdings (Private) Ltd, Temasek Holdings, ranked by reported 13F value among the 76 institutional holders on this page.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q4 2023 | 64 | 64.29M | $5.17B | +8.6% |
| Q3 2023 | 42 | 57.71M | $161.06M | -8.9% |
| Q2 2023 | 14 | 11.39M | $43.39M | +0.1% |
| Q1 2023 | 12 | 10.16M | $18.89M | +0.0% |
| Q4 2022 | 10 | 10.04M | $23.10M | -2.2% |
| Q3 2022 | 12 | 10.39M | $33.45M | -3.4% |
| Q2 2022 | 11 | 11.06M | $60.85M | -7.5% |
| Q1 2022 | 15 | 12.11M | $28.22M | -20.5% |
Over the 8 quarters shown, institutional share counts increased 431% in aggregate (Q1 2022 → Q4 2023); the largest single-quarter swing was Q1 2022 (-20.5%).
Top Institutional Holders (Q4 2023) — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 451.17K | $4.53B | 0.83% | New | |
| 9.59M | $96.27M | 0.54% | Reduce | |
| 9.59M | $96.27M | 0.70% | Reduce | |
| 9.55M | $95.85M | 7.85% | Reduce | |
| 9.31M | $93.46M | 1.87% | Hold | |
| 5.00M | $50.22M | 11.43% | Add | |
| 4.51M | $45.33M | 5.03% | Add | |
| 2.19M | $22.00M | 2.03% | Add | |
| 2.08M | $20.88M | 0.24% | Add | |
| 1.46M | $14.67M | 0.37% | New | |
| 1.38M | $13.80M | 3.50% | Hold | |
| 1.35M | $13.55M | 0.03% | Add | |
| 1.28M | $12.85M | 2.66% | New | |
| 1.28M | $12.84M | 0.66% | New | |
| 596.61K | $5.99M | 0.96% | New | |
| 517.27K | $5.19M | 0.02% | Add | |
| 511.95K | $5.14M | 0.00% | Add | |
| 502.94K | $5.05M | 0.93% | Reduce | |
| 400.00K | $4.02M | 4.72% | New | |
| 510.00K | $3.31M | 0.07% | Add | |
| 266.67K | $2.68M | 0.03% | Reduce | |
| 192.47K | $1.93M | 0.01% | Add | |
| 191.27K | $1.92M | 0.00% | Add | |
| 191.27K | $1.92M | 0.00% | Add | |
| 130.78K | $1.31M | 0.07% | New |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q3 2023 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 10.88M | $31.34M | 3.43% | New | |
| 9.90M | $28.52M | 0.17% | New | |
| 9.90M | $28.52M | 0.21% | Hold | |
| 9.31M | $26.81M | 0.59% | New | |
| 3.04M | $8.75M | 1.29% | New | |
| 2.52M | $7.27M | 1.04% | New | |
| 2.08M | $5.99M | 1.85% | New | |
| 1.53M | $4.41M | 0.95% | New | |
| 1.38M | $3.96M | 1.58% | New | |
| 1.00M | $2.88M | 0.02% | New | |
| 850.00K | $2.45M | 0.01% | New | |
| 759.39K | $2.19M | 0.02% | New | |
| 579.67K | $1.67M | 0.32% | New | |
| 2.00M | $1.13M | 0.02% | New | |
| 311.52K | $897.18K | 0.00% | New | |
| 484.52K | $873.50K | 0.02% | New | |
| 275.00K | $792.00K | 0.05% | New | |
| 159.09K | $458.17K | 0.07% | New | |
| 119.49K | $344.13K | 0.00% | Reduce | |
| 98.65K | $284.11K | 0.00% | Add | |
| 86.64K | $249.53K | 0.01% | New | |
| 65.13K | $187.56K | 0.00% | Add | |
| 61.58K | $177.34K | 0.00% | New | |
| 46.60K | $134.00K | 0.00% | Reduce | |
| 43.33K | $124.80K | 0.00% | Add |
Q2 2023 — 14 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 9.90M | $37.73M | 0.27% | Hold | |
| 1.00M | $3.81M | 0.02% | New | |
| 225.63K | $859.64K | 0.00% | New | |
| 63.46K | $241.79K | 0.00% | Reduce | |
| 51.91K | $197.78K | 0.00% | Add | |
| 49.10K | $187.00K | 0.00% | Hold | |
| 37.37K | $142.36K | 0.00% | Add | |
| 24.37K | $92.86K | 0.00% | Reduce | |
| 17.25K | $65.74K | 0.00% | Reduce | |
| 10.21K | $38.90K | 0.00% | Add | |
| 2.74K | $10.42K | 0.00% | Add | |
| 2.30K | $8.76K | 0.00% | Reduce | |
| 2.27K | $8.63K | 0.00% | Add | |
| 1.22K | $4.66K | 0.00% | Add |
Q1 2023 — 12 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 9.90M | $18.42M | 0.14% | Hold | |
| 78.67K | $146.33K | 0.00% | New | |
| 48.90K | $91.00K | 0.00% | Hold | |
| 33.16K | $61.69K | 0.00% | Hold | |
| 32.10K | $59.71K | 0.00% | New | |
| 24.84K | $46.21K | 0.00% | Add | |
| 17.47K | $32.49K | 0.00% | Reduce | |
| 8.12K | $15.11K | 0.00% | Add | |
| 4.52K | $8.41K | 0.00% | Add | |
| 2.57K | $4.78K | 0.00% | Reduce | |
| 2.20K | $4.00K | 0.00% | Add | |
| 760 | $1.41K | 0.00% | Reduce |
Q4 2022 — 10 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 9.90M | $22.77M | 0.17% | Hold | |
| 49.00K | $113.00K | 0.00% | Reduce | |
| 33.16K | $76.00K | 0.00% | Hold | |
| 22.30K | $51.28K | 0.00% | Reduce | |
| 20.46K | $47.06K | 0.00% | Reduce | |
| 4.28K | $9.85K | 0.00% | Reduce | |
| 3.63K | $8.35K | 0.00% | Reduce | |
| 3.60K | $8.27K | 0.00% | Reduce | |
| 2.02K | $5.00K | 0.00% | Reduce | |
| 771 | $1.77K | 0.00% | Add |
Q3 2022 — 12 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 9.90M | $31.88M | 0.23% | Hold | |
| 219.11K | $705.00K | 0.00% | Reduce | |
| 93.91K | $302.00K | 0.00% | Hold | |
| 50.30K | $162.00K | 0.00% | Add | |
| 33.16K | $106.00K | 0.00% | Hold | |
| 30.24K | $97.00K | 0.00% | Reduce | |
| 24.65K | $79.00K | 0.00% | New | |
| 23.32K | $75.00K | 0.00% | Reduce | |
| 4.63K | $15.00K | 0.00% | Reduce | |
| 3.90K | $13.00K | 0.00% | New | |
| 3.27K | $11.00K | 0.00% | Add | |
| 718 | $2.00K | 0.00% | Reduce |
New Positions (latest)
No fund opened a new position this quarter.
Fully Exited (vs previous quarter)
No tracked fund fully exited this quarter.
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MMCAP International Inc. SPC | 451.17K | — | — | — | — | — | — | — | — | — | — |
| Temasek Holdings (Private) Ltd | 9.59M | 9.90M | — | — | — | — | — | — | — | — | — |
| Temasek Holdings | 9.59M | 9.90M | 9.90M | 9.90M | 9.90M | 9.90M | 9.90M | 9.90M | 9.90M | 9.90M | — |
| Vivo Capital, LLC | 9.55M | 10.88M | — | — | — | — | — | — | — | — | — |
| ORBIMED ADVISORS LLC | 9.31M | 9.31M | — | — | — | — | — | — | — | — | — |
| Sio Capital Management, LLC | 5.00M | 2.08M | — | — | — | — | — | — | — | — | — |
| TCG Crossover Management, LLC | 4.51M | 3.04M | — | — | — | — | — | — | — | — | — |
| TANG CAPITAL MANAGEMENT LLC | 2.19M | 159.09K | — | — | — | — | — | — | — | — | — |
| BAKER BROS. ADVISORS LP | 2.08M | 1.00M | — | — | — | — | — | — | — | — | — |
| Pentwater Capital Management LP | 1.46M | — | — | — | — | — | — | — | — | — | — |
| Pivotal bioVenture Partners Investment Advisor LLC | 1.38M | 1.38M | — | — | — | — | — | — | — | — | — |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.35M | 850.00K | — | — | — | — | — | — | — | — | — |
| TIG Advisors, LLC | 1.28M | — | — | — | — | — | — | — | — | — | — |
| ALPINE ASSOCIATES MANAGEMENT INC. | 1.28M | — | — | — | — | — | — | — | — | — | — |
| Octagon Capital Advisors LP | 596.61K | — | — | — | — | — | — | — | — | — | — |
| Qube Research & Technologies Ltd | 517.27K | 2.63K | — | — | — | — | — | — | — | — | — |
| Bank of America Corp | 511.95K | 665 | 2.30K | 8.12K | 4.28K | 30.24K | 58.46K | 86.20K | 86.34K | 24.09K | — |
| SPHERA FUNDS MANAGEMENT LTD. | 502.94K | 1.53M | — | — | — | — | — | — | — | — | — |
| HARVEST MANAGEMENT LLC | 400.00K | — | — | — | — | — | — | — | — | — | — |
| LMR Partners LLP | 510.00K | 484.52K | — | — | — | — | — | — | — | — | — |
FAQ
Which funds hold GRCL?
76 funds have reported positions in GRCL across five years of 13F filings; the sum of their latest reported stakes is $5.18B.
Who are the top institutional holders of GRCL?
The largest 13F holders are MMCAP International Inc. SPC, Temasek Holdings (Private) Ltd, Temasek Holdings, Vivo Capital, LLC, ORBIMED ADVISORS LLC; the top 25 are ranked at the top of this page.
Who are the major shareholders of GRACELL BIOTECHNOLOGIES INC?
The major shareholders of GRACELL BIOTECHNOLOGIES INC (GRCL) by reported 13F value are MMCAP International Inc. SPC, Temasek Holdings (Private) Ltd, Temasek Holdings, Vivo Capital, LLC, ORBIMED ADVISORS LLC, among 76 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.